Digitized image analysis reveals diffuse abnormalities in normal- appearing white matter during acute experimental autoimmune encephalomyelitis

Journal of Neuroscience Research

Volumn 54, Issue 3, 1998, Pages 364-372

  Kawczak, Julie A ^a   Mathisen, Peter M ^a   Drazba, Judith A ^a   Fuss, Babette ^a   Macklin, Wendy B ^a   Tuohy, Vincent K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Autoimmunity; Demyelination; Encephalomyelitis; Magnetic resonance imaging; Multiple sclerosis; Myelin proteolipid protein

Indexed keywords

PROTEOLIPID PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; FEMALE; GENE EXPRESSION; IMAGE ANALYSIS; INFLAMMATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WHITE MATTER;

EID: 0032213532     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-4547(19981101)54:3<364::aid-jnr7>3.0.co;2-%23     Document Type: Article

References (43)

1. Boccaccio GL, Steinman L (1996): Multiple sclerosis: from a myelin point of view. J Neurosci Res 45:647-654.
2. Brenner T, Brocke S, Szafer F, Sobel RA, Parkinson JF, Perez DH, Steinman L (1997): Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J Immunol 158:2940-2946.
3. Chomczynski P, Sacchi N (1987): Single-step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Analytical Biochem 162:156-159.
4. Comi G, Rocca MA, Rovaris M, Martino G, Minicucci L, Gironi M, Filippi M (1998): Magnetization transfer changes in the normal-appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Neurology 50(suppl 4):A191 (abstr S17.005).
5. Cross AH, Manning PT, Stern MK, Misko TP (1997): Evidence for the production of peroxynitrite in inflammatory CNS demyelination. J Neuroimmunol 80:121-130.
6. Danielson PE, Forss-Peter S, Brow MA, Calavetta L, Douglas J, Milner RJ, Sutcliffe JG (1988): p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA 7:261-267.
7. De Stefano N, Matthews PM, Narayanan S, Francis GS, Antel JP, Arnold DL (1997): Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient. Neurology 49:1138-1141.
8. Ding M, Zhang M, Wong JL, Rogers NE, Ignarro LJ, Voskuhl RR (1998): Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J Immunol 160:2560-2564.
9. Eng LF, Ghirnikar RS, Lee YL (1996): Inflammation in EAE: role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem Res 21:511-525.
10. Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997): Axonal damage in acute multiple sclerosis lesions. Brain 120:393-399.
11. Fuss B, Baba H, Phan T, Tuohy VK, Macklin WB (1997): Phosphodiesterase I, a novel adhesion molecule and/or cytokine involved in oligodendrocyte function. J Neurosci 17:9095-9103.
12. Godiska R, Chantry D, Dietsch GN, Gray PW (1995): Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol 58:167-176.
13. + lesions in normal appearing white matter (NAWM). Neurology 50(suppl 4):A191 (abstr S17.004).
14. Kalman B, Lublin FD (1998): Cytokine therapy. In: Zhang J, Hafler D, Hohlfeld R, Miller A (eds): "Immunotherapy in Neuroimmunologic Diseases." Martin Dunitz, London, England, pp. 261-278.
15. Karpus WJ, Kennedy KJ (1997): Mip-1α and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J Leukoc Biol 62:681-687.
16. Lees MB (1998): A history of proteolipids: a personal memoir. J Neurochem Res 23:261-271.
17. Linington C (1998): Experimental animal models. In: Zhang J, Hafler D, Hohlfeld R, Miller A (eds): "Immunotherapy in Neuroimmunologic Diseases." Martin Dunitz, London, England, pp. 11-28.
18. Martin R, McFarland HF, McFarlin DE (1992): Immunological aspects of demyelinating diseases. Annu Rev Immunol 10:153-187.
19. Mathisen PM, Yu M, Johnson JM, Drazba JA, Tuohy VK (1997): Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J Exp Med 186:159-164.
20. Matthews PM, Pioro E, Narayanan S, De Stefano N, Fu L, Francis G, Antel J, Wolfson C, Arnold DL (1996): Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 119:715-722.
21. Mayer-Proschel M, Rao MS, Noble M (1997): Progenitor cells of the central nervous system: a boon for clinical neuroscience. J NIH Res 9:31-36.
22. Narayanan S, Fu L, Pioro E, De Stefano N, Collins DL, Francis GS, Antel JP, Matthews PM, Arnold DL (1997): Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Annal Neurol 41:385-391.
23. Newman S, Kitamura K, Campagnoni AT (1987): Identification of a cDNA coding for a fifth form of myelin basic protein in mouse. Proc Natl Acad Sci USA 84:886-890.
24. + glial cells are distinct from resting and activated microglia. J Neurosci Res 48:299-312.
25. Olsson T (1995): Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev 144:245-268.
26. Pan JW, Hetherington HP, Vaughan JT, Mitchell G, Pohost GM, Whitaker JN (1996): Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T. Magn Reson Med 36:72-77.
27. Peters AR, Geelen JA, den Boer JA, Prevo RL, Minderhoud JM, Gravenmade EJ (1995): A study of multiple sclerosis patients with magnetic resonance spectroscopic imaging. Mult Scler 1:25-31.
28. Raine CS (1984): Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 50:608-635.
29. Ransohoff RM (1997): Chemokines in neurological disease models: Correlation between chemokine expression patterns and inflammatory pathology. J Leukoc Biol 62:645-652.
30. Rooney WD, Goodkin DE, Schuff N, Meyerhoff DJ, Norman D, Weiner MW (1997): 1H MRSI of normal appearing white matter in multiple sclerosis. Mult Scler 3:231-237.
31. Roser W, Hagberg G, Mader I, Brunnschweiler H, Radue EW, Seelig J, Kappos L (1995): Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magn Reson Med 33:811-817.
32. Sarchielli P, Presciutti O, Tarducci R, Gobbi G, Alberti A, Pelliccioli GP, Orlacchio A, Gallai V (1998): 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study. J Neurol Neurosurg Psychiatry 64:204-212.
33. Schiepers C, Van Hecke P, Vandenberghe R, Van Oostende S, Dupont P, Demaerel P, Bormans G, Carton H (1997): Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis. Mult Scler 3:8-17.
34. 1 mice with acute experimental allergic encephalomyelitis induced with two different synthetic peptides of myelin proteolipid protein. J Immunol 146:543-549.
35. Sorg BA, Smith MM, Campagnoni AT (1987): Developmental expression of the myelin proteolipid protein and basic protein mRNAs in normal and dysmyelinating mutant mice. J Neurochem 49:1146-1154.
36. Steinman L (1996): A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc Natl Acad Sci USA 93:2253-2256.
37. Steinman L (1996): Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system. Cell 85:299-302.
38. Tourbah A, Stievenart JL, Iba-Zizen MT, Zannoli G, Lyon-Caen O, Cabanis EA (1996): In vivo localized NMR proton spectroscopy of normal appearing white matter in patients with multiple sclerosis. J Neuroradiol 23:49-55.
39. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, and Bo L (1998): Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285.
40. Tuohy VK, Lu Z, Sobel RA, Laursen RA, Lees MB (1989): Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol 142:1523-1526.
41. Tuohy VK, Thomas DM (1995): Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice. J Neuroimmunol 56:161-170.
42. Yu M, Nishiyama A, Trapp BD, Tuohy VK (1996): Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. J Neuroimmunol 64:91-100.
43. Zamvil SS, Steinman L (1990): The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 8:579-621.